| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| SPENCER MC | CLINICAL LIMITATIONS OF EXPERIMENTAL CUTANEOUS MONILIASIS (CANDIDA ALBICANS). | 1963 | Arch Dermatol | pmid:14071472 |
| Coskey RJ | Contact dermatitis due to nystatin. | 1971 | Arch Dermatol | pmid:5552354 |
| STONE OJ and MULLINS JF | EXPERIMENTAL STUDIES ON CHRONIC PARONYCHIA. | 1964 | Arch Dermatol | pmid:14096373 |
| Stroud JD and Van Dersarl JV | Striae. | 1971 | Arch Dermatol | pmid:5539499 |
| Cahill KM et al. | Primary cutaneous aspergillosis. | 1967 | Arch Dermatol | pmid:6054229 |
| White MI and Main RA | The treatment of Hallopeau's acrodermatitis. | 1979 | Arch Dermatol | pmid:426542 |
| Bradford LG and Montes LF | Perioral dermatitis and Candida albicans. | 1972 | Arch Dermatol | pmid:4555327 |
| Coskey RJ and Bryan HG | Letter: Contact dermatitis due to perfume in Mycolog cream. | 1975 | Arch Dermatol | pmid:47237 |
| Chalmers D | Letter: Subclinical infection. | 1974 | Arch Dermatol | pmid:4852939 |
| Maize JC and Lynch PJ | Chronic mucocutaneous candidiasis of the adult. A report of a patient with an associated thymoma. | 1972 | Arch Dermatol | pmid:5009626 |
| Petrozzi JW and Witkowski JA | Acrodermatitis perstans. Generalization following therapy with nystatin. | 1971 | Arch Dermatol | pmid:5091870 |
| Wasilewski C | Allergic contact dermatitis from nystatin. | 1970 | Arch Dermatol | pmid:5430317 |
| Carter VH and Olansky S | Haloprogin and nystatin therapy for cutaneous candidiasis. Comparison of the efficacy of haloprogin and nystatin therapy. | 1974 | Arch Dermatol | pmid:4608934 |
| Ward DB et al. | Characterization of diaper dermatitis in the United States. | 2000 | Arch Pediatr Adolesc Med | pmid:10980800 |
| Hernandez-Machin B et al. | Picture of the month: diagnosis. | 2007 | Arch Pediatr Adolesc Med | pmid:17768292 |
| CARTER JJ et al. | Nystatin in the control of fungous overgrowth during large bowel chemotherapy. | 1960 | Arch Surg | pmid:13808034 |
| Dyess DL et al. | Candida sepsis. Implications of polymicrobial blood-borne infection. | 1985 | Arch Surg | pmid:3970669 |
| Desai MH et al. | Candida infection with and without nystatin prophylaxis. A 11-year experience with patients with burn injury. | 1992 | Arch Surg | pmid:1540092 |
| Cerra FB et al. | Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. | 1992 | Arch Surg | pmid:1540093 |
| Burchard KW et al. | Fungal sepsis in surgical patients. | 1983 | Arch Surg | pmid:6849638 |